![Luigi Naldini](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 M $ in data 31/07/2026
Luigi Naldini is the founder of Magenta Therapeutics, Inc. founded in 2015.
Dr. Naldini is the founder of Epsilen Bio Srl founded in 2019.
Dr. Naldini was the founder of Genenta Science SpA founded in 2014 and held the title of Chairman-Executive Scientific Board.
Dr. Naldini is the founder of GenAspire Srl founded in 2020.
Dr. Naldini is also the founder of nChroma Bio, Inc.,Chroma Medicine, Inc...
Dr. Naldini is Director at San Raffaele-Telethon Institute for Gene Therapy.
Dr. Naldini is Director at American Society of Gene & Cell Therapy.
Dr. Naldini is Professor at Università Vita-Salute San Raffaele.
Dr. Naldini was President at European Society of Gene & Cell Therapy.
Dr. Naldini earned doctorates from the University of Turin and Università degli Studi di Roma Tor Vergata.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
GENENTA SCIENCE SPA 7,61% | 04/05/2026 | 1.386.145 ( 7,61% ) | 2 M $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
San Raffaele-Telethon Institute for Gene Therapy | Direttore/Membro del Consiglio | - |
Università Vita-Salute San Raffaele
 Università Vita-Salute San Raffaele Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
Chroma Medicine, Inc.
 Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Fondatore | - |
European Society of Gene & Cell Therapy | Presidente | - |
Epsilen Bio Srl
 Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Develops therapies for genetic diseases | Fondatore | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
University of Turin
 University of Turin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Society of Gene & Cell Therapy | |
Università degli Studi di Roma Tor Vergata
 Università degli Studi di Roma Tor Vergata Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Università Vita-Salute San Raffaele
Università Vita-Salute San Raffaele Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Raffaele-Telethon Institute for Gene Therapy | |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Commercial Services |
Genenta Science SpA
 Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Epsilen Bio Srl
Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Develops therapies for genetic diseases | Health Technology |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
